# TRANSPLANTATION & CELLULAR THERAPY MEETINGS OF ASTCT AND CIBMTR

## Filter by content:
- **Types**
  - Newly diagnosed multiple myeloma
  - Relapsed/refractory multiple myeloma
- **Therapeutics**
  - Auto-HSCT
  - CAR therapy
  - Ciltacabtagene autoleucel
  - Idecabtagene vicleucel
  - Lenalidomide
  - P-BCMA-ALLO1
- **Congresses**
  - CAR-T 2024
  - TCT 2023
  - TCT 2024
  - TCT 2025
- **Trials**
  - CARTITUDE-2
  - CARTITUDE-4
- **Expert Opinions**
  - Surbhi Sidana
- **Educational Resources**

## Articles

1. [2025 Tandem Meetings | Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR congress coverage](/content/medical-information/2025-tandem-meetings-or-transplantation-and-cellular-therapy-meetings-of-astct-and-cibmtr/index.html)
   
   - **Date**: Feb 21, 2025

2. [Integrating cilta-cel into earlier lines of therapy: Rationale and latest data from CARTITUDE-2 and CARTITUDE-4](/content/medical-information/integrating-cilta-cel-into-earlier-lines-of-therapy-rationale-and-latest-data-from-cartitude-2-and-cartitude-4/index.html)
   
   - **Date**: Apr 1, 2024

3. [CARTITUDE-2 cohorts A and B: Updated efficacy and safety results](/content/medical-information/cartitude-2-cohorts-a-and-b-updated-efficacy-and-safety-results/index.html)
   
   - **Date**: Mar 7, 2024

4. [Are CAR T-cell therapies safe for patients with impaired renal function?](/content/medical-information/are-car-t-cell-therapies-safe-for-patients-with-impaired-renal-function/index.html)
   
   - **Date**: Jul 11, 2023

5. [Chronic opioid use following auto-HSCT in patients with MM](/content/medical-information/chronic-opioid-use-following-auto-hsct-in-patients-with-mm/index.html)
   
   - **Date**: Mar 13, 2023

## All Congresses

- **[American Association for Cancer Research](/content/congresses/american-association-for-cancer-research/index.html)**
- **[American Society of Clinical Oncology](/content/congresses/asco/index.html)**
- **[American Society of Hematology](/content/congresses/ash/index.html)**
- **[Controversies in Multiple Myeloma](/content/congresses/comy/index.html)**
- **[EHA–EBMT European CAR T-Cell Meeting](/content/congresses/car-t-meetings/index.html)**
- **[European Hematology Association](/content/congresses/eha/index.html)**
- **[European Myeloma Network](/content/congresses/emn18-1/index.html)**
- **[European School of Haematology](/content/congresses/esh/index.html)**
- **[European Society for Blood and Marrow Transplantation](/content/congresses/ebmt/index.html)**
- **[European Society For Medical Oncology](/content/congresses/esmo-2023/index.html)**
- **[International Academy for Clinical Hematology](/content/congresses/iach/index.html)**
- **[International Myeloma Society](/content/congresses/ims2022-1/index.html)**
- **[International Myeloma Workshop](/content/congresses/imw/index.html)**
- **[Lymphoma, Leukemia and Myeloma](/content/congresses/llm/index.html)**
- **[National Comprehensive Cancer Network](/content/congresses/nccn/index.html)**
- **[Other Events](/content/congresses/other/index.html)**
- **[Society of Hematologic Oncology](/content/congresses/soho/index.html)**